Vaxcyte (NASDAQ:PCVX – Get Free Report) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports. PCVX has been the topic of a number of other reports. Weiss Ratings restated a “sell (d-)” rating on shares of Vaxcyte in a research note on Monday, […]

eToro Group (NASDAQ:ETOR – Get Free Report) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Tuesday,Zacks.com reports. A number of other brokerages also recently commented on ETOR. Keefe, Bruyette & Woods raised their price objective on shares of eToro Group from $35.00 […]

Forgent Power Solutions (NYSE:FPS – Get Free Report) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports. Other equities analysts have also issued reports about the stock. The Goldman Sachs Group upped their price target on shares of Forgent Power […]

Electronic Arts (NASDAQ:EA – Get Free Report) was downgraded by investment analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Monday,Zacks.com reports. Other equities research analysts have also recently issued research reports about the stock. Weiss Ratings raised shares of Electronic Arts from a “hold […]

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports. Several other research analysts have also recently issued reports on the stock. Wall Street Zen cut shares of Protagonist Therapeutics from a “strong-buy” rating […]

Nexa Resources (NYSE:NEXA – Get Free Report) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Wednesday,Zacks.com reports. A number of other analysts also recently issued reports on the stock. Wall Street Zen raised shares of Nexa Resources from a “buy” rating to […]

Immunocore (NASDAQ:IMCR – Get Free Report) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports. IMCR has been the subject of several other reports. Jefferies Financial Group lowered Immunocore from a “buy” rating to a “hold” rating and reduced their […]

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports. Other equities analysts have also recently issued research reports about the company. Weiss Ratings restated a “sell (e+)” rating on shares of Akebia […]

Kenvue (NYSE:KVUE – Get Free Report) was downgraded by stock analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports. KVUE has been the topic of a number of other research reports. UBS Group lowered their price objective on Kenvue from $19.00 to $18.00 and […]

Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Monday,Zacks.com reports. Several other research analysts also recently issued reports on the company. Guggenheim upped their price objective on Monte Rosa Therapeutics from $30.00 to $35.00 and gave […]

RLJ Lodging Trust (NYSE:RLJ – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports. A number of other research analysts also recently issued reports on the company. Wall Street Zen raised RLJ Lodging Trust from a […]

Helen of Troy (NASDAQ:HELE – Get Free Report) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports. HELE has been the topic of several other reports. Canaccord Genuity Group boosted their target price on Helen of Troy from […]

Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Monday,Zacks.com reports. Other equities research analysts have also recently issued reports about the stock. Weiss Ratings upgraded shares of Monte Rosa Therapeutics from a […]

Globus Medical (NYSE:GMED – Get Free Report) was downgraded by research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday,Zacks.com reports. GMED has been the topic of several other reports. Royal Bank Of Canada raised their price target on Globus Medical from $115.00 to $120.00 and […]

FMC (NYSE:FMC – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Wednesday,Zacks.com reports. Several other equities research analysts have also commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of FMC from […]